SanBio Company Limited provided earnings guidance for the first half and full year of the fiscal year ending January 31, 2021. For the full year, the company expected Operating loss of JPY 5,453 million, ordinary loss of JPY 5,543 million and net loss attributable to owners of parent of JPY 5,544 million or JPY 107.06 per share. For the first half, the company expected Operating loss of JPY 2,710 million, ordinary loss of JPY 2,759 million and net loss attributable to owners of parent of JPY 2,760 million or JPY 53.30 per share.